Vironix AI, founded in 2020, is a digital health company based in the United States. It develops an AI-powered virtual care management platform designed for remote monitoring and detection services, specifically targeting patients with chronic conditions.
The company's core product, the Virtual Care Platform, enables healthcare providers to deliver advanced remote monitoring and chronic care management. The platform operates across the AI, digital health, and remote patient monitoring domains.
Reported outcomes associated with the platform include a 42% reduction in hospital readmissions, a 35% improvement in patient adherence, and a 58% increase in drug interaction detection.
